Resgen

Has Resgen declared dividend?

No Dividend History Available

Who are the peers of the Resgen?

Resgen's peers include Reliance Industries, ONGC, IOC, BPCL, HPCL, Continental Petroleums, Real Eco-Energy, Greenhitech, Aakash Explorations, and Arabian Petrol. While some peers show excellent management and growth, Resgen has below-average growth and capital structure, with a 1-year return of -15.09%.

Peers: The peers of Resgen are Reliance Industr, ONGC, I O C L, B P C L, HPCL, Cont. Petroleums, Real Eco-Energy, Greenhitech, Aakash Explor, and Arabian Petrol.<BR><BR>Quality Snapshot: Excellent management risk is observed at ONGC, I O C L, B P C L, HPCL, and Cont. Petroleums, while Average management risk is found at Reliance Industr, Resgen, and Arabian Petrol. Good growth is noted at ONGC, I O C L, B P C L, HPCL, Reliance Industr, and Greenhitech, while Resgen, Real Eco-Energy, and Aakash Explor exhibit below-average growth. Good capital structure is present at Reliance Industr, ONGC, I O C L, B P C L, and Cont. Petroleums, while Resgen, HPCL, and Arabian Petrol have below-average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Cont. Petroleums at 50.31%, while the lowest is ONGC at -16.16%. Resgen's own 1-year return is -15.09%, which is higher than ONGC's but lower than Cont. Petroleums. Additionally, the six-month return is negative for ONGC, I O C L, and Real Eco-Energy.

What is the technical trend for Resgen?

As of June 6, 2025, Resgen's technical trend has shifted to a bearish stance, supported by bearish MACD, moving averages, and Bollinger Bands, despite a mildly bullish KST signal and no momentum from the RSI.

As of 6 June 2025, the technical trend for Resgen has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. The weekly MACD is bearish, and daily moving averages confirm this bearish trend. Additionally, the weekly Bollinger Bands and Dow Theory indicate a mildly bearish outlook. The KST shows a mildly bullish signal, but it does not outweigh the overall bearish indicators. The RSI shows no signal on both weekly and monthly time frames, suggesting a lack of momentum. Overall, the combination of these indicators supports a bearish sentiment in the current market environment.

Who are in the management team of Resgen?

As of March 2022, the management team of Resgen includes Karan Atul Bora (Managing Director), Abhijeet Oza Ashok (Executive Director), Milind Rane (Director), and independent directors Shruti Mahesh Rambhia and Brandon Alvestine Almeida. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Resgen includes the following individuals:<BR><BR>1. Karan Atul Bora - Managing Director<BR>2. Abhijeet Oza Ashok - Executive Director<BR>3. Milind Rane - Director<BR>4. Shruti Mahesh Rambhia - Independent Director<BR>5. Brandon Alvestine Almeida - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What does Resgen do?

Resgen Ltd is a micro-cap company in the oil industry, originally incorporated in 2018 and converted to a public company in 2022. It currently has no reported sales or profits, with a market cap of INR 176 Cr and a P/E ratio of 22.00.

Overview:<BR>Resgen Ltd operates in the oil industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Resgen Limited was originally incorporated on September 29, 2018, as a Private Limited Company under the name "Ecojanitors Private Limited." In 2022, the company converted to a Public Limited Company and changed its name to "Ecojanitors Limited," receiving a Fresh Certificate of Incorporation on July 01, 2022. There is no sales or profit data reported for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 176 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 22.00<BR>Industry P/E: 39<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.17<BR>Return on Equity: 16.08%<BR>Price-to-Book: 3.63<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the top shareholders of the Resgen?

The top shareholders of Resgen are primarily the promoters, with Karan Atul Bora holding 64.9% of the shares. Individual investors own 25.48%, while other public shareholders account for 3.25%, indicating a significant majority held by the promoter group.

The top shareholders of Resgen primarily include the promoters, with Karan Atul Bora holding the highest stake at 64.9%. There are no mutual funds or foreign institutional investors (FIIs) involved in the shareholding. Additionally, individual investors collectively hold 25.48% of the shares, while other public shareholders account for 3.25%. Overall, the promoter group holds a significant majority of the company's shares.

How big is Resgen?

As of 24th July, Resgen Ltd has a market capitalization of 178.00 Cr, classifying it as a Micro Cap company. Recent financial data, including quarterly performance, is unavailable, but as of March 2024, shareholder's funds are valued at 49.61 Cr and total assets at 65.53 Cr.

As of 24th July, Resgen Ltd has a market capitalization of 178.00 Cr, which classifies it as a Micro Cap company.<BR><BR>There is no valid financial data available for the latest quarterly performance, including Net Sales and Net Profit for the latest four quarters.<BR><BR>For the balance sheet snapshot, the reporting period is March 2024. Shareholder's Funds are valued at 49.61 Cr, and Total Assets amount to 65.53 Cr.

When is the next results date for Resgen?

The next results date for Resgen is 14 November 2025.

The next results date for Resgen is scheduled for 14 November 2025.

How has been the historical performance of Resgen?

Resgen has shown significant growth from March 2021 to March 2025, with net sales increasing from 0.02 crore to 65.16 crore, and profit after tax rising to 7.98 crore from 0.01 crore. The company has also improved its operating profit and cash flow, reflecting strong overall financial performance.

Answer:<BR>The historical performance of Resgen shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025.<BR><BR>Breakdown:<BR>Resgen's net sales have increased dramatically from 0.02 crore in March 2021 to 65.16 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.02 crore in March 2021 to 65.16 crore in March 2025. The company's total expenditure also grew, from 0.01 crore in March 2021 to 49.78 crore in March 2025, with raw material costs being the largest component. Operating profit (PBDIT) has shown consistent improvement, reaching 15.38 crore in March 2025, up from just 0.01 crore in March 2021. Profit before tax increased from 0.01 crore in March 2021 to 11.14 crore in March 2025, and profit after tax rose to 7.98 crore in March 2025 from 0.01 crore in March 2021. The company's total assets grew from 1.62 crore in March 2020 to 69.94 crore in March 2025, while total liabilities increased from 1.62 crore to 69.94 crore in the same period. Cash flow from operating activities improved significantly, reaching 7.00 crore in March 2025, compared to a negative cash flow of 14.00 crore in March 2023. Overall, Resgen has demonstrated robust growth in sales, profits, and asset accumulation over the past few years.

Is Resgen overvalued or undervalued?

As of November 18, 2025, Resgen is considered undervalued with a valuation grade upgrade to very attractive, supported by favorable ratios like a PE of 20.29 and a PEG of 0.95, making it a compelling investment opportunity compared to higher PE ratios of peers like Larsen & Toubro and CG Power & Industries, despite its recent stock performance lagging behind the Sensex.

As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential.<BR><BR>In comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlying valuation suggests that Resgen presents a compelling investment opportunity.

Why is Resgen Ltd falling/rising?

As of 16-Mar, Resgen Ltd's stock price is at 55.00, showing a minor increase but reflecting significant declines of 19.19% year-to-date and 37.80% over the past year. The stock is trading below key moving averages, indicating a bearish outlook, despite a recent uptick in investor participation.

As of 16-Mar, Resgen Ltd's stock price is currently at 55.00, reflecting a slight increase of 0.1 (0.18%). Despite this minor rise, the stock has experienced significant declines over various periods, including a year-to-date drop of 19.19% and a one-year decrease of 37.80%. <BR><BR>Today, the stock hit a new 52-week low of Rs.53, indicating a downward trend. Furthermore, Resgen is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bearish outlook. However, there has been a notable increase in investor participation, with a delivery volume of 8.25k on March 13, rising by 3.77% compared to the 5-day average. This could indicate some level of interest from investors despite the overall negative performance.<BR><BR>In summary, while there is a slight uptick in the stock price today, the broader context shows that Resgen Ltd has been underperforming significantly over the past year and year-to-date, contributing to a generally negative sentiment around the stock.

Which are the latest news on Resgen?